Ascendis Pharma A/S (ASND)

227.87 +0.56 (+0.25%) USD  |  NASDAQ  |  Oct 02, 16:00
227.96 +0.09 (+0.04%) After-Hours: 20:00
More

Ascendis Pharma Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Quarterly Actual Revenue Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
June 30, 2025 --
Date Value
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --
June 30, 2024 --

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Novo Nordisk A/S Upgrade
Evaxion AS Upgrade
Genmab A/S Upgrade
Zealand Pharma A/S Upgrade